• European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera and will be marketed by STADA• Launch preparations are underway to bring the second approved golimumab biosimilar to patients acro...
View DetailsGuangzhou, China, December 24, 2024 - Bio-TheraSolutions Inc.(688177:SH),a commercial-stage biopharmaceutical company developing a pipeline ofinnovative therapies and a pipeline of biosimilars, today announced the companyhas partnered with Tabuk Phar...
GUANGZHOU, China - Bio-Thera Solutions, a commercial-stage biopharmaceutical companydeveloping innovative therapies and biosimilars today announced an expansion oftheir partnership with SteinCares today with the addition of a third biosimilarto the p...
Guangzhou, China/Budapest, Hungary– # October 9,2024 – Bio-Thera Solutions (688177:SH; “Bio-Thera”), a commercial-stagebiopharmaceutical company developing a pipeline of innovative therapies andbiosimilars, and Gedeon Richter (“Richter”) announce tod...
